Dohmen Acquires Reglera, a Denver-based Consulting and Services Partner to the Medical Device Industry

Sixth acquisition in two-years for the 154-Year-Old Healthcare Services Company

Dohmen Acquires Reglera, a Denver-based Consulting and Services Partner to the Medical Device Industry

Dohmen CompanyCarole PfeilVP, Corporate CommunicationsDirect: 414.299.4914Cell: 414.335.1749

CEO Cynthia (Dohmen) LaConte announced today that the Dohmen Company has acquired Reglera, a leading provider of quality assurance and regulatory affairs consulting services to the medical device and human cellular tissue industries including regulatory strategies & submissions, quality system development, compliance remediation, complaint handling & adverse event reporting and contract manufacturing.

"As personalized medicine becomes an increasingly viable healthcare model, traditional lines between pharma, bio, tissue and devices begin to blur. Expanding our medical device capability became the next logical step in our strategic plan to provide a holistic suite of support services to Life Science companies that are making the transition to therapeutic care companies," said LaConte. "We acquired Reglera because they share our culture, values and vision -- but they also bring significant experience in pre-commercial support services as well as a strong understanding of the tissue and stem cell segment."

Reglera's President Clay Anselmo agrees, "We're in lockstep with Dohmen's vision of creating a more efficient, affordable and accessible healthcare supply system. We built our medical device and human tissue business and became one of the world's largest consulting firms in these segments because we've focused upon increasing efficiencies and shortening time-to-market for our clients. The competitive nature of the medical device industry coupled with increasing regulatory oversight is driving great demand for our services. By joining Dohmen we're assured the strategic support needed to really accelerate our growth."

LaConte said Reglera's capabilities have expanded Dohmen's service offerings to Life Science companies to include:

Reglera is Dohmen's second acquisition this year. In April of 2012, Dohmen acquired BioSoteria, a leader in drug safety, pharmacovigilence services and drug safety training tools. In 2011, Dohmen acquired three companies; PlanIT, a health analytics firm; MedComm Solutions, a clinical call center and medical information fulfillment operation; and Centric Health Resources, a provider of distribution and health management services that connects life science companies to patients with rare disease. Dohmen plans to continue to expand its service portfolio through innovation and acquisition.

Since 1858, has been creating a more efficient, affordable and accessible healthcare supply system, first as an apothecary, then as a manufacturer, later as a wholesaler and today as a provider of outsourced business services. Our companies reduce cost and complexity for healthcare producers and payers. , , and bring best practice services to life science companies in the areas of supply chain, patient services, payment, compliance and drug safety. , and bring best practice services to healthcare consumers that simplify the purchase and use of healthcare products.

Based in Wheat Ridge, Colorado, Reglera is a consulting and service partner to more than 500 hundred medical device and human cellular tissue companies seeking best practice in the areas of regulatory compliance and quality assurance. With one of the largest consulting staffs in the industry including hundreds of experts in device and tissue located in the US and Israel, Reglera has helped both small start-ups and global corporations accelerate growth and profitability with comprehensive consulting and outsourcing services. For more information regarding Reglera visit or contact Brian Tucker at 1.800.341.4255 or .